NLRP3 and IgA glomerulonephritis: Collectively, these findings demonstrate that osthole exerts its therapeutic effects in IgA nephropathy primarily by targeting renal oxidative stress and interrupting the ROS–NF-κB–NLRP3 inflammatory cascade—positioning it as a promising multi-target natural agent for disease modification.